Immunocore Holdings plc

Item 5.07. Submission of Matters to a Vote of Security Holders. On May 27, 2026, Immunocore Holdings plc (the “Company”) held its 2026 Annual General Meeting of Shareholders (the “AGM”). The shareholders considered the ten resolutions set forth below, each of which were voted on and duly passed on a poll at the AGM. Each resolution is described in more detail in the Company’s definitive proxy statement filed with the Securities and Exchange Commission on April 16, 2026 (the “Proxy Statement”). Set forth below are the results, including the number of votes cast for, against and abstentions, with respect to each of the resolutions submitted for a vote of the shareholders at the AGM. An abstention is not a vote in law and is not counted in the calculation of the proportion of the votes for or against a particular resolution. Ordinary Resolutions Resolution 1: To re-appoint as a director of the Company Siddharth Kaul. The votes were cast as follows: For Against Abstain ──────────────────────────────────────── 38,033,664 261,819 8,357 Resolution 2: To re-appoint as a director of the Company William Pao, M.D., Ph. D. The votes were cast as follows: For Against Abstain ──────────────────────────────────────── 38,040,755 254,852 8,233 Resolution 3: To re-appoint as a director of the Company Kristine Peterson. The votes were cast as follows: For Against Abstain ────────────────────────────────────────── 29,537,800 8,744,383 21,657 Resolution 4: To approve, on an advisory basis, the compensation of the Company’s named executive officers, as disclosed in the Proxy Statement. The votes were cast as follows: For Against Abstain ────────────────────────────────────────── 29,682,169 8,600,029 21,642 Resolution 5: To ratify the appointment of Deloitte LLP, a limited liability partnership organized under the laws of England, as the Company’s U.S. independent registered public accounting firm for the year ending December 31, 2026. The votes were cast as follows: For Against Abstain ──────────────────────────────────────── 38,294,666 984 8,190 Resolution 6: To re-appoint Deloitte LLP, a limited liability partnership organized under the laws of England, as the Company’s U.K. statutory auditors, to hold office until the conclusion of the next annual general meeting of shareholders. The votes were cast as follows: For Against Abstain ──────────────────────────────────────── 38,294,523 966 8,351 Resolution 7: To authorize the audit committee to determine the U.K. statutory auditors’ remuneration for the year ending December 31, 2026. The votes were cast as follows: For Against Abstain ──────────────────────────────────────── 38,293,269 2,481 8,090 Resolution 8: To receive and adopt the U.K. statutory annual accounts and reports for the year ended December 31, 2025 (the “2025 U.K. Annual Report”). The votes were cast as follows: For Against Abstain ──────────────────────────────────────── 38,287,987 944 14,909 Resolution 9: To approve the directors’ remuneration report for the year ended December 31, 2025, which is set forth as Annex A to the Proxy Statement and on pages 26 to 56 of the 2025 U.K. Annual Report (excluding the directors’ remuneration policy set out on pages A-5 to A-15 of Annex A to the Proxy Statement). The votes were cast as follows: For Against Abstain ────────────────────────────────────────── 29,504,692 8,713,573 85,575 Resolution 10: To authorize the Company to make political donations/incur political expenditure. The votes were cast as follows: For Against Abstain ──────────────────────────────────────── 38,213,340 82,113 8,387